Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment
Feifei Yang, Ting Hu, Jianquan Liu, Xiaoqian Yu, Liying Ma
Topics & Concepts
ImmunotherapyCancer immunotherapyCancerHistone deacetylaseHistoneImmune systemCancer researchImmunologyChemistryMedicineInternal medicineDNABiochemistryHistone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsMultiple Myeloma Research and Treatments